Canada Lawyers Representing People Injured by Advair Asthma
Inhalers
FDA Forces Advair Maker to Add Warnings
August 9, 2004—The FDA announced that
it will require GlaxoSmithKline to include more stringent
warnings relating to potentially life-threatening side effects
of Advair. A similar warning was also added to GSK's Serevent,
a similar asthma drug.
Advair News
Our firm has compiled important information
on the latest developments on the asthma drug Advair. We encourage
you to visit the Advair news page for
more details on the Advair warning.
Advair Lawyers Canada
Greg Monforton and Partners is handling legal
claims against GlaxoSmithKline on behalf of Canadians injured
by the drug Advair.
If you or a loved one has been seriously injured
as a result of Advair, we encourage you to contact us. We
will represent clients throughout Canada in lawsuits against
GlaxoSmithKline.
For free answers to your questions about the Advair lawsuit,
please complete our online contact form.
August 9, 2004—GlaxoSmithKline Plc's asthma drugs Serevent
and Advair will carry new warnings
about a small risk of life-threatening asthma episodes or asthma-related deaths,
the Food and Drug Administration said Thursday.
